2023 Changping Forum on Medical & Health Finance and Investment Innovation Opens for Registration | Listening to Voices of Innovation and Exploring Value Creation in the Life Sciences Industry

The biopharmaceutical industry is one of the key arenas in the new round of technological revolution and competition.As a vital component of the bioeconomy, the biopharmaceutical industry has maintained rapid growth in recent years. Hailed as the global “Fifth Wave of Wealth” following the information technology sector, it is characterized by skewed capital allocation, sustained leadership by industry giants, and innovative enterprises achieving overtaking on bends.Transitioning from a major pharmaceutical country to a powerful one, and shifting R&D innovation from imitation-based to independent innovation, is an inherent requirement for the development of China’s pharmaceutical and healthcare industry during the 14th Five-Year Plan period.

Financing is the lifeline of pharmaceutical innovation, playing a crucial role in driving research and development and accelerating commercial success in the life sciences industry. The White Paper on the Global Layout and Development Trends of the Pharmaceutical and Healthcare Industry points out that global innovative elements are accelerating their aggregation, and the external funding environment has become one of the three major challenges facing the pharmaceutical and healthcare industry. Data shows that the total financing amount in the healthcare industry in the first half of 2023 was the lowest since the first half of 2018, reaching only RMB 41.1 billion, a decrease of RMB 23.7 billion compared to the first half of 2022. Affected by multiple uncertainties, the pace of investment and financing has slowed down, and companies’ valuations for the next round of funding remain “flat.”

Nevertheless, judging from the number and volume of financing deals in the global and Chinese pharmaceutical and healthcare industries, this sector remains a key focus for capital investment. However, the structure of hot sub-sectors has undergone significant changes, which also benefits innovative enterprises in further deepening their layout in blue-ocean markets that have not yet solidified.The “fertile ground” of medical innovation urgently needs a steady influx of “financial vitality.”

In recent years, Beijing has attached great importance to the development of the biopharmaceutical industry. In accelerating the construction of an international science and technology innovation center, Beijing has focused on key areas such as scientific and technological innovation, biopharmaceuticals, and the digital economy, achieving fruitful results. According to data released at the 2023 China International Fair for Trade in Services (CIFTIS), the overall scale of Beijing’s pharmaceutical and health industry has grown rapidly, with an output value of RMB 891.6 billion in 2022, an average annual growth rate of 7.9% over five years, and 85 listed companies. As an important carrier area of Beijing’s International Science and Technology Innovation Center and a highland for innovation in Beijing’s pharmaceutical and health industry, Changping District is actively building multi-channel and multi-level enterprise service platforms, continuously promoting institutional innovation and supply chain openness in the biopharmaceutical industry.Notably, the fund-of-funds system for technology and industry established by Changping District in Beijing has invested in over 330 pharmaceutical and healthcare projects across China.

To accelerate the construction of the globally leading “Life Valley” and create a “tipping point” for Beijing’s pharmaceutical and health industry, thereby jointly promoting its high-quality development, Changping District is committed to building an evergreen International Forum on Life Sciences. In November 2022, the 2022 Beijing·Changping International Forum on Life Sciences was held. Concurrently, the Medical Health Financial Investment Innovation Forum, a special event of the main forum, kicked off online. Focusing on multiple fields including biopharmaceuticals, medical devices, and smart healthcare, nearly 40 experts, scholars, and corporate representatives gathered to discuss future trends in the global medical health industry in the post-pandemic era. Participants included Zhao Weijiu, Party Group Member, Deputy Director, and Spokesperson of the Beijing Municipal Local Financial Supervision and Administration Bureau; Wang Lei, Party Group Member and Deputy Director of the Beijing Municipal Bureau of Economy and Information Technology; Liu Xiaodong, Member of the Standing Committee of the Changping District Committee of the Communist Party of China, Party Group Member of the District Government, and Deputy District Mayor; Huang Lei, Director of the Market Development Department of the National Equities Exchange and Quotations (NEEQ) and Beijing Stock Exchange; Shao Feng, Deputy Director of Scientific Research at the National Institute of Biological Sciences, Beijing; Li Xiang, Managing Director and Member of the Investment Banking Business Management Committee of China International Capital Corporation (CICC); He Wenbin, Co-Chief Pharmaceutical Analyst at Haitong Securities; Yuan Quanhong, Partner at Hankang Capital; Cai Daqing, Founding Partner at Sherpa Investments; and Yang Ruirong, Partner at Yuanyi Capital. They deeply explored new opportunities and challenges for the innovative development of China’s medical health industry under the new paradigm from various perspectives, providing new insights for primary and secondary market capital and medical innovation enterprises to grasp industrial directions.

Currently, the 2023 Changping International Life Science Forum is in intensive preparation.As one of the thematic forums of the 2023 Changping International Life Science Forum, registration is now officially open for the 2023 Pharmaceutical and Healthcare Financial Investment Innovation Forum.This forum is hosted by the People's Government of Changping District, Beijing, and jointly organized by the Administrative Committee of Future Science City (Life Science Park Administrative Committee), the Administrative Committee of Changping Park of Zhongguancun Science Park, the Financial Services Office of Changping District, Beijing, Beijing Changping Science and Technology Park Development Co., Ltd., Beijing Zhongguancun Life Science Park Development Co., Ltd., and VCBeat VB100.Leveraging the unique resource advantages of Changping District, we will actively attract and support various financial institutions and funds to establish and develop their operations in Changping, precisely empowering enterprises across the investment ecosystem. With financial regulatory experts, macroeconomists, medical industry policy specialists, representatives from stock exchanges, representatives from government-guided and market-oriented fund-of-funds at all levels, prominent investment firms specializing in healthcare sectors, life science innovation scientists, and executives from life science startups and innovative enterprises as key participants, we will listen to insights from academic, financial, and industrial leaders driving innovation in pharmaceuticals and healthcare, exploring value investment and value creation in the future life health industry.

Prior to this grand event,Special Planning by the Forum Organizing Committee: The Innovator’s Solution, The Innovator’s Insight, we hope to hear more voices from innovators and investors across various sub-sectors of the pharmaceutical and healthcare industry, uncover rich value perspectives, and contribute to the future development of pharmaceutical and healthcare investment.

I. Event Overview

Based on industry development trends and the proposed keynote speeches/roundtable discussions of the forum, we have launched the initiative “The Innovator’s Question,” calling upon innovators across the pharmaceutical and healthcare sectors to submit their “Innovator’s Answers.” Through this quest for solutions, the Organizing Committee aims to identify innovative approaches to key challenges in the development and investment of the pharmaceutical and healthcare industries, thereby helping to shape a collaborative environment for the forum and the industry at large. We look forward to a vibrant exchange of diverse perspectives.

II. Participants

Representatives of Innovators Serving the Greater Health Industry, Including Innovative Enterprises, Investment Institutions, Industrial Parks, and Securities Firms

III. Submission Period

September 19–October 15

IV. Exhibition Planning

V. Returns on Selection and Collaborative Promotion

1. One VIP ticket with front-row seating for the 2023 Changping Pharmaceutical and Health Financial Investment Innovation Forum (buffet included).

2. Obtain the 2023 Annual Investment and Financing Report Collection and the Pharmaceutical and Healthcare Industry Report Collection from VCBeat (VBInsight).

3. Receive one ticket to the VCBeat VB100 2023 Healthcare Equity Investment Conference.

4. High-quality innovative answers will be published in the form of articles, posters, and offline exhibition boards. Authors of high-quality answers will have the opportunity to be invited to share their insights in relevant thematic sections of the forum.

5. Receive a set of passes for the Changfazhan Pharmaceutical & Health HIBIO series, granting free access to all HIBIO salons, forums, summits, and other events throughout 2024.

6. Opportunity to receive targeted invitations to related activities for the 2024 Changping Pharmaceutical and Health Industry Cluster Visits, engaging in discussions on future strategic development with park leadership, representatives of innovative medical enterprises, and other stakeholders.

VI. Submission Channels and Important Notes

· Submission Channel

Scan the code to participate

·Precautions

1. The respondent shall answer at least one question,Each answer must contain no fewer than 100 words., answers may include articles published within the past year, links to industry research interviews, etc.;

2. All textual submissions for this event are subject to review by the Organizing Committee. If the content meets the requirements, a staff member will contact the author.

I. Event Overview

Call for "Innovators' Insights" Videos from Across the Industry on Topics Including the Development of the Pharmaceutical and Healthcare Sector, Investment in the Industry, and Park Construction in Changping District. Video content may cover reflections on this year’s healthcare investment market, key themes in healthcare investment for 2023, outlooks for the healthcare industry in 2024, and well-wishes for this forum. Participating enterprises, institutions, or individuals may submit their entries through the designated channels. The Organizing Committee aims to gather the most authentic perspectives and heartfelt best wishes from across the industry through this initiative.Injecting surging momentum into the 2023 Changping Pharmaceutical and Health Finance Investment Innovation Forum, and stimulating innovative power.

II. Participants

Innovative enterprise representatives serving the big health industry, including investment institutions, industrial parks, and securities firms (this event will specially invite industry leaders and elites in pharmaceuticals, healthcare, and medical investment to participate)

III. Call for Video Submissions

1. Briefly introduce the video recorder and their affiliated enterprise or institution;

2. Discuss the key themes of healthcare investment in 2023 and share your perspectives on this year’s healthcare investment market;

3. Outlook for the Future of the Healthcare Industry in 2024;

4. Best wishes for the 2023 Changping Pharmaceutical and Health Finance Investment Innovation Forum, e.g., “Wishing the 2023 Changping Pharmaceutical and Health Finance Investment Innovation Forum a complete success.”

IV. Submission Period

September 19–October 27

V. Exhibition Planning

VI. Selection/Joint Promotion Benefits

1. Selected congratulatory videos will be compiled into a video montage and played as a warm-up before the opening of the 2023 Changping Pharmaceutical and Health Financial Investment Innovation Forum.

2. One VIP ticket with front-row seating for the 2023 Changping Pharmaceutical and Healthcare Financial Investment Innovation Forum (including buffet).

3. Obtain the 2023 Annual Collection of Investment and Financing Reports and the Collection of Pharmaceutical and Healthcare Industry Reports from VCBeat.

4. Receive one ticket to the VCBeat VB100 2023 Healthcare Equity Investment Conference.

5. Receive a set of combo tickets for the Changfazhan Pharmaceutical Health HIBIO series events, granting free access to HIBIO salons, forums, summits, and other activities throughout 2024.

6. Eligible for targeted invitations to visitation activities organized by the Changping Pharmaceutical and Health Industry Cluster in 2024, enabling discussions on future strategic development with park leadership and representatives from innovative medical enterprises.

VII. Submission Channels and Important Notes

1. Video Submission Channel: Please send the video to peng.x@vcbeat.net by October 27.

2. Submission Guidelines

① The video duration shall not exceed 3 minutes; any content exceeding this limit will be edited by the organizing committee.

② Please package a clear half-body or full-body photo of the interviewee (business attire is recommended) together with the original greeting message/video file (please do not add any image elements or subtitles in post-production) and send them to: peng.x@vcbeat.net

③ The email subject line must be formatted as “Innovator’s Insights + Company/Organization Name + Interviewee’s Name + Job Title”;

④ Please send the subtitle text in Word format to the email address;

⑤ Videos submitted for this call must be reviewed by the Organizing Committee; those meeting the visual and content requirements will be selected. The final videos will be produced centrally by the Organizing Committee and shared with participating partners for publication on their own corporate channels, in conjunction with the 2023 Changping Medical and Health Financial Investment Innovation Forum.

⑥ Excellent Reference Example: Video Shooting Sample for “Insights of Innovators” (Click to view for reference on visuals and recording quality)

Forum Name:2023 Changping Pharmaceutical and Health Financial Investment Innovation Forum

Forum Time:November 17, 2023

Forum Venue:Beijing · Changping · Taikang Academy

Forum Scale:300–400 people

Forum Organizing Committee:

Organizer:

People's Government of Changping District, Beijing Municipality

Organizer:

Future Science City Management Committee (Life Science Park Management Committee)

Management Committee of Changping Park, Zhongguancun Science Park

Beijing Changping District Financial Services Office

Beijing Changping Science and Technology Park Development Co., Ltd.

Beijing Zhongguancun Life Science Park Development Co., Ltd.

Beijing Danhuang Technology Co., Ltd. (VCBeat VB100)

Ticket Benefits:

1. Includes the report released at this forum (electronic version)

2. On-site Resource Coordination Group

3. Transcripts of Selected Guest Speeches and Roundtable Discussions from the Forum

4. Forum Lunch Voucher

Forum Q&A and Media Cooperation:

VB100 Ms. Peng - 13364027163 (WeChat ID same)

VB100 Ms. Zou - 15213067481 (WeChat ID same as phone number)